Bio-Rad Laboratories, Inc. Class A Common Stock vs NRG Energy Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while NRG Energy Inc trades at $121.21 (market cap $24.83B). The key difference: NRG Energy Inc is far larger — about 2.6× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and NRG Energy Inc pays a 1.61% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | NRG | |
|---|---|---|
Market Cap | $9.43B | $24.83B |
Sector | Health | Utilities |
52-Week High | $356.25 | $184.03 |
52-Week Low | $241.71 | $117.04 |
Enterprise Value | $9.18B | $48.79B |
Dividend Yield | — | 1.61% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →